By regulating the Acod1/ITA axis or the downstream UBR5‐PAD4 signaling pathway, and by using 4‐OI with good cell membrane permeability, new therapeutic strategies can be developed, which can effectively reduce the inflammatory burden of sepsis patients and improve their prognosis. Here, UBR5 is linked to Sepsis.